EE423 The Cost Savings Potential Associated with the Use of Nefecon for Adults with Primary IgA Nephropathy in the United States
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.689
https://www.valueinhealthjournal.com/article/S1098-3015(23)03819-6/fulltext
Title :
EE423 The Cost Savings Potential Associated with the Use of Nefecon for Adults with Primary IgA Nephropathy in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03819-6&doi=10.1016/j.jval.2023.09.689
First page :
Section Title :
Open access? :
No
Section Order :
10176